Immunogenicity 13809
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
TAS2R3
Transcript ID
uc003vwp.1
HLA INFO
A*24:02
TCR INFO
No TCR info found!
Full length protein sequence (316 aa)
MMGLT
1
EGVFL
6
ILSGT
11
QFTLG
16
ILVNC
21
FIELV
26
NGSSW
31
FKTKR
36
MSLSD
41
FIITT
46
LALLR
51
IILLC
56
IILTD
61
SFLIE
66
FSPNT
71
HDSGI
76
IMQII
81
DVSWT
86
FTNHL
91
SIWLA
96
TCLGV
101
LYCLK
106
IASFS
111
HPTFL
116
WLKWR
121
VSRVM
126
VWMLL
131
GALLL
136
SCGST
141
ASLIN
146
EFKLY
151
SVFRG
156
IEATR
161
NVTEH
166
FRKKR
171
SEYYL
176
IHVLG
181
TLWYL
186
PPLIV
191
SLASY
196
SLLIF
201
SLGRH
206
TRQML
211
QNGTS
216
SRDPT
221
TEAHK
226
RAIRI
231
ILSFF
236
FLFLL
241
YFLAF
246
LIASF
251
GNFLP
256
KTKMA
261
KMIGE
266
VMTMF
271
YPAGH
276
SFILI
281
LGNSK
286
LKQTF
291
VVMLR
296
CESGH
301
LKPGS
306
KGPIF
311
S
316
Mutation Information
DNA mutation:
None
Peptide Range:
265 ~ 289
Mut AA position:
277 (13 in Wild Type peptide)
Alignment
Wild Type:
"AKMIGEVMTMFYPAGHSFILILGNS
||||||||||||.||||||||||||
Mutant:
AKMIGEVMTMFYSAGHSFILILGNS"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) TAS2R3
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay